Literature DB >> 12947985

Neutrophils in the antitumoral immune response.

E Di Carlo1, G Forni, P Musiani.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12947985     DOI： 10.1159/000071561

Source DB:  PubMed          Journal:  Chem Immunol Allergy        ISSN： 0079-6034


× No keyword cloud information.
  36 in total

1.  Pre-treatment neutrophil-to-lymphocyte ratio predicts prognosis in patients with locoregionally advanced laryngeal carcinoma treated with chemoradiotherapy.

Authors:  Yue-Can Zeng; Feng Chi; Rui Xing; Ming Xue; Li-Na Wu; Mei-Yue Tang; Rong Wu
Journal:  Jpn J Clin Oncol       Date:  2015-11-25       Impact factor: 3.019

2.  Significance of the preoperative neutrophil-to-lymphocyte ratio in the prognosis of patients with gastric cancer.

Authors:  Liang Yu; Cheng-Yu Lv; Ai-Hua Yuan; Wei Chen; An-Wei Wu
Journal:  World J Gastroenterol       Date:  2015-05-28       Impact factor: 5.742

3.  Activation state of stromal inflammatory cells in murine metastatic pancreatic adenocarcinoma.

Authors:  Douglas D Benson; Xianzhong Meng; David A Fullerton; Ernest E Moore; Joon H Lee; Lihua Ao; Christopher C Silliman; Carlton C Barnett
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2012-03-14       Impact factor: 3.619

4.  Neutrophil/lymphocyte ratio predicts the prognosis in esophageal squamous cell carcinoma patients.

Authors:  Keisuke Kosumi; Yoshifumi Baba; Takatsugu Ishimoto; Kazuto Harada; Kenichi Nakamura; Mayuko Ohuchi; Yuki Kiyozumi; Daisuke Izumi; Ryuma Tokunaga; Katsunobu Taki; Takaaki Higashi; Tatsunori Miyata; Junji Kurashige; Yukiharu Hiyoshi; Shiro Iwagami; Yasuo Sakamoto; Yuji Miyamoto; Naoya Yoshida; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2015-06-03       Impact factor: 2.549

5.  Standardized pretreatment inflammatory laboratory markers and calculated ratios in patients with oral squamous cell carcinoma.

Authors:  Martin Grimm; Johan Rieth; Sebastian Hoefert; Michael Krimmel; Sven Rieth; Peter Teriete; Susanne Kluba; Thorsten Biegner; Adelheid Munz; Siegmar Reinert
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

6.  Pre-treatment neutrophil to lymphocyte ratio as a prognostic marker to predict chemotherapeutic response and survival outcomes in metastatic advanced gastric cancer.

Authors:  In Rae Cho; Jun Chul Park; Chan Hyuk Park; Jung Hyun Jo; Hyun Jik Lee; Sunyong Kim; Choong Nam Shim; Hyuk Lee; Sung Kwan Shin; Sang Kil Lee; Yong Chan Lee
Journal:  Gastric Cancer       Date:  2014-01-19       Impact factor: 7.370

7.  The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis.

Authors:  Shouyu Wang; Zhen Zhang; Fengqi Fang; Xue Gao; Wei Sun; Huanran Liu
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

8.  Factors impacting survival following second surgery in patients with glioblastoma in the temozolomide treatment era, incorporating neutrophil/lymphocyte ratio and time to first progression.

Authors:  Mairéad G McNamara; Zarnie Lwin; Haiyan Jiang; Arnoud J Templeton; Gelareh Zadeh; Mark Bernstein; Caroline Chung; Barbara-Ann Millar; Normand Laperriere; Warren P Mason
Journal:  J Neurooncol       Date:  2014-01-28       Impact factor: 4.130

9.  Sequential cancer immunotherapy: targeted activity of dimeric TNF and IL-8.

Authors:  Stefan Bauer; Nicole Adrian; Uta Siebenborn; Natalie Fadle; Margarita Plesko; Eliane Fischer; Thomas Wüest; Frank Stenner; Joachim C Mertens; Alexander Knuth; Gerd Ritter; Lloyd J Old; Christoph Renner
Journal:  Cancer Immun       Date:  2009-03-09

10.  Tumour cell lines HT-29 and FaDu produce proinflammatory cytokines and activate neutrophils in vitro: possible applications for neutrophil-based antitumour treatment.

Authors:  Antonio Brú; Juan-Carlos Souto; Sonia Alcolea; Rosa Antón; Angel Remacha; Mercedes Camacho; Marta Soler; Isabel Brú; Amelia Porres; Luis Vila
Journal:  Mediators Inflamm       Date:  2010-02-11       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.